Regulatory decisions that keep pace with your innovation
For medtech and digital health teams that need to break through the regulatory complexity holding back their time-to-market.
Inside many medtech companies, product development moves quickly while regulatory answers arrive slowly, inconsistently, and only after significant time and cost have already been spent.
Behind these delays the patients you are on a mission to help are waiting longer for access to safe and effective innovation.
Sounds familiar?
Speed mismatch
Your products move fast. Your regulatory process does not.
Manual overload
RA and QA spend hours searching, cross-checking, and summarizing regulatory content.
Waiting loops
Teams wait days or weeks for answers on classification and regulatory pathways.
Shifting assumptions
Early product decisions rely on assumptions that change after deeper regulatory review.
Inconsistent checks
Pre-submission reviews vary by reviewer, product, and timing.
Costly fallback
External consultants are expensive and rarely available when timelines tighten.
Unpredictable outcome
Slow decisions, late surprises, and senior experts stuck in PDFs instead of moving products and trials forward.
Guideways automates the most time-consuming regulatory tasks around classification, pathways, requirements, and compliance reviews. Your team stays in control of decisions, but the search and review processes now happen in the background.
AI agents purpose-built for regulatory approval and compliance
Guideways acts as your regulatory guide, giving you expert-level insight the moment you describe your product. Guideways focuses on the steps where you lose the most time and certainty: planning, internal alignment, and submission preparation.
FDA Sherpa
Understand your path early
Turn a device description into clear classification options and likely regulatory pathways, identify relevant predicates along with key regulations and guidances, and use this insight to plan clinical and development strategy based on evidence rather than guesswork.
FDA Reviewer
Find gaps before regulators do
Map documents against identified requirements, flag missing sections, inconsistencies, and weak support, and get a structured submission readiness view with clear, prioritized actions.
FDA Researcher
Stronger answers, fewer document deep-dives
Regulatory research tuned to medtech questions, delivering results pulled from regulations, guidances, standards, and approvals, with structured answers and linked references you can use directly in memos, risk assessments, and justifications.
Guideways supports the points where regulatory work slows teams down
Intake and early discussion for new devices
Internal pre-submission reviews and sign-off
Cross-functional meetings around regulatory strategy
Ongoing questions from R&D and clinical teams
Outputs can be exported and attached to the systems you already use. RA/QA stays in charge of interpretation and decisions. Guideways makes the underlying analysis more consistent, traceable, and easier to explain.
“Guideways made it easy and accessible for us to quickly assess where we stand and how to proceed.”
What you get back in time and control?
Get a faster path from device idea to a realistic regulatory route, avoid late-stage surprises in requirements and documentation, and make better use of limited RA/QA capacity across projects. You’ll also have clearer documentation of regulatory reasoning for audits and internal reviews, and rely less on consultants for repeatable work so you can use them where they add the most value. If this sounds familiar, we can show the full workflow on one of your devices in a live demo.
We can show the full workflow on one of your devices in a live demo.
